Association of neuropeptide Y receptor Y5 polymorphisms with dyslipidemia in Mexican Americans

Obesity

Volumn 15, Issue 4, 2007, Pages 809-815

  Coletta, Dawn K ^a   Schneider, Jennifer ^b   Stern, Michael P ^a   Blangero, John ^b   DeFronzo, Ralph A ^a   Duggirala, Ravindranath ^b   Jenkinson, Christopher P ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Dyslipidemia; Genetic susceptibility; Insulin resistance; Metabolic syndrome; Neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y RECEPTOR;

ADULT; ALLELE; ARTICLE; DYSLIPIDEMIA; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HISPANIC; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC SYNDROME X; MEXICAN AMERICANS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NEUROPEPTIDE Y;

EID: 34248339628     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.610     Document Type: Article

References (27)

1. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA. 1982;79: 5485-9.
2. Dryden S, Frankish H, Wang Q, Williams G. Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest. 1994;24:293-308.
3. Stanley BG, Leibowitz SF. Neuropeptide Y injected into the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci USA. 1985;82:3940-3.
4. Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol. 1987;252:599-609.
5. Stanley BG, Anderson KC, Grayson MH, Leibowitz SF. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol Behav. 1989;46:173-7.
6. Beck B, Stricker-Krongrad A, Nicols JP, Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding of obese Zucker rats. Int J Obesity. 1992;16:295-302.
7. Friedman JM. The alphabet of weight control. Nature. 1997; 385:119-20.
8. Blomqvist AG, Herzog H. Y-receptor subtypes: how many more? Trends Neurosci. 1997;20:294-8.
9. Kalra SP, Kalra PS. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides. 2004;38:201-11.
10. Schaffhauser AO, Stricker-Krongrad A, Brunner L, et al. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes. 1997;46:1792-8.
11. Rosenkranz K, Hinney A, Ziegler A, et al. Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes. Int J Obes. 1998;22: 157-63.
12. Blumenthal JB, Andersen RE, Mitchell BD, et al. Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels. Clin Genet. 2002;62:196-202.
13. Jenkinson CP, Cray K, Walder K, Herzog H, Hanson R, Ravussin E. Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians. Int J Obes. 2000;24:580-4.
14. Stern MP, Gaskill SP, Hazuda HP, Gardner LI, Haffner SM. Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia. 1983;24:272-7.
15. Collins-Schramm HE, Chima B, Morii T, et al. Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians. Hum Genet. 2004;114:263-71.
16. Bergman RN, Zaccaro DJ, Watanabe RM, et al. Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes. 2003;52:2168-74.
17. Herzog H, Darby K, Ball H, Hort Y, Beck-Sickinger A, Shine J. Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggest coordinate transcriptional regulation. Genomics. 1997;41:315-9.
18. Duggirala R, Blangero J, Almasy L, et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet. 1999;64:1127-40.
19. Permutt MA, Wasson JC, Suarez BK, et al. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes. 2001;50:681-5.
20. Prochazka M, Lillioja S, Tait JF, et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes. 1993;42:514-9.
21. Stern MP, Mitchell BD, Blangero J, et al. Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes. 1996;45:563-8.
22. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol. 1984; 120:834-51.
23. Duggirala R, Blangero J, Almasy L, et al. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet. 2001;68:1149-64.
24. Almasy L, Blangero J. Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62: 1198-211.
25. Abecasis GR, Cookson WO, Cardon LR. Pedigree tests of transmission disequilibrium. Eur J Hum Genet. 2000;8:545-51.
26. Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. Ann Hum Genet. 1986;50:181-94.
27. Blangero J, Goring HH, Kent JW Jr, et al. Quantitative trait nucleotide analysis using Bayesian model selection. Hum Biol. 2005;77:541-59.